Format

Send to

Choose Destination
Histol Histopathol. 2007 Sep;22(9):1043-9. doi: 10.14670/HH-22.1043.

Prostate stem cells and cancer.

Author information

1
Department of Biomedical Sciences, Cornell University, Ithaca, New York, USA. an58@cornell.edu

Abstract

Properties shared by neoplastic and stem cells indicate a possibility that somatic stem cells or transit-amplifying cells that have reacquired stem cell properties, particularly the ability for self-renewal, represent favorable targets for malignant transformation. In this review we discuss significance of the stem cell model for understanding prostate cancer pathogenesis and describe relevant studies in animals. It is proposed that dissemination of rare cancer stem cells may lead to metastatic disease and that resistance of such cells to multiple drugs and androgen ablation make them responsible for failure of current treatments. Thus further understanding of the cancer stem cell biology is needed for development of efficient rationally designed therapy permitting better targeting and better treatment outcomes for patients with prostate neoplasms.

PMID:
17523082
DOI:
10.14670/HH-22.1043
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Sercrisma International S.L.
Loading ...
Support Center